ArticleJournal of ovarian research2026
Role of immune cells in clear cell ovarian cancer: a two-sample bidirectional Mendelian randomization study.
Article in Journal of ovarian research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRecent investigations reported an association between clear cell ovarian cancer(CCOC) and abnormal immune regulation, but the causal relationship among this association and specific immune cell the features needs further elucidation. The aim of the research conducted had been to investigate the potential causal impact of immune cell traits on CCOC applying a bivariate example Mendelian randomization(MR) journey.
methodsWe gathered genome-wide association study (GWAS) data on 731 categories of immunological cells and clear cell ovarian cancer from the currently published literature. To find the genetic associations between various immune cell traits and the risk of clear cell ovarian cancer, we employed inverse variance weighting (IVW) as the primary analysis technique and carried out sensitivity analyses to confirm the accuracy of the findings.
resultsThis study found that six immune features were associated with an increased risk of clear cell ovarian cancer, including various T-cell and B-cell markers. The results of reverse MR analysis show that clear cell ovarian cancer can lower the level of CD3 on CD39 + resting Treg. Sensitivity analysis showed no heterogeneity or level-dependent pleiotropy.
conclusionThis study reveals the possible genetic connected among immunophenotype and the danger of CCOC, providing new genetic ideas for understanding the connection with immune cells and clear cell ovarian cancer, while providing theoretical support for exploring the pathogenesis and immunotherapy of CCOC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.